-
De Nove Malignancies after Liver Transplantation: Single Center Experience in Korea
-
De Novo Belatacept in Clinical Vascularized Composite Allotransplantation
-
De Novo Donor Specific Antibodies in Pediatric Kidney Transplant Recipients Are Highly Responsive to Therapy
-
De Novo DSA against Third Party Extension Vessels Used in Kidney and Pancreas Transplantation
-
De Novo or Early Conversion to Everolimus and the Risk of Skin Cancers in Kidney Transplant Recipients: A Trial-Based Linkage Study
-
De Novo Use of Extended Released Tacrolimus (Meltdose, EnvasusR)) after OLT – Does the Colonic Resorption Influences the Outcome?
-
Death-Censored Graft Failure (DCGF) Post Kidney Transplant (KTx) is Usually the Result of Rapid Loss of Function after Periods of Stability
-
Deceased Donor Initiated Kidney Transplant Exchanges and the Forgotten Incompatible Directed Donor Recipients
-
Deceased Donor Urinary Biomarker Signature and the Effectiveness of Peritransplant Lymphocyte Depletion on Early Renal Allograft Function
-
Deceased Pediatric Donor Livers: How Current Policy Drives Allocation and Transplantation
- « Previous Page
- 1
- …
- 38
- 39
- 40
- 41
- 42
- …
- 211
- Next Page »